Molecular Pharmacology. 63 3 : 699-705. Doi:10.1124 mol.63.3.699
Research of the effects on abnormal cannabidiol in mice has indicated that atypical cannabinoids have therapeutic potential in a variety of inflammatory conditions, including those of the gastrointestinal tract. After inducing colitis by means of trinitrobenzene sulfonic acid, wound healing of both human umbilical vein endothelial and epithelial cells was enhanced by the Abn-CBD. Adams MD, Earnhardt JT, Martin BR, Harris LS, Dewey WL, Razdan RK (September 1977). "A cannabinoid with cardiovascular activity but no overt behavioral effects". Experientia. 33 (9): Terra Pro Product 1204-1205. doi:10.1007/BF01922330. McHugh D, Terra Pro Product Hu SS, Rimmerman N, Juknat A, Vogel Z, Terra Pro CBD Walker JM, et al. March 2010). "N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor". Citti C, Russo F, Linciano P, Strallhofer SS, Tolomeo F, Forni F, et al. 2021). "Origin of Δ9-Tetrahydrocannabinol Impurity in Synthetic Cannabidiol". Cannabis and Cannabinoid Research. 6 (1): 28-39. doi:10.1089/can.2020.0021. Járai Z, Wagner JA, Varga K, Terra Pro Formula Lake KD, Compton DR, Martin BR, et al.
November 1999). "Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors". Proceedings of the National Academy of Sciences of the United States of America. Walter L, Franklin A, Witting A, Wade C, Xie Y, Kunos G, et al. February 2003). "Nonpsychotropic cannabinoid receptors regulate microglial cell migration". The Journal of Neuroscience. Offertáler L, Mo FM, Bátkai S, Liu J, Begg M, Razdan RK, Terra Pro Product et al. March 2003). "Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor". Molecular Pharmacology. 63 (3): 699-705. doi:10.1124/mol.63.3.699. Milman G, Maor Y, Abu-Lafi S, Horowitz M, Gallily R, Batkai S, et al. February 2006). "N-arachidonoyl L-serine, an endocannabinoid-like brain constituent with vasodilatory properties". Proceedings of the National Academy of Sciences of the United States of America. 103 (7): 2428-2433. Bibcode:2006PNAS..103.2428M. McCollum L, Howlett AC, Mukhopadhyay S (June 2007). "Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells".
The Journal of Pharmacology and Experimental Therapeutics. Ryberg E, Larsson N, Sjögren S, Hjorth S, Hermansson NO, Leonova J, et al. December 2007). "The orphan receptor GPR55 is a novel cannabinoid receptor". British Journal of Pharmacology. 152 (7): 1092-1101. doi:10.1038/sj.bjp.0707460. Kapur A, Zhao P, Sharir H, Bai Y, Caron MG, Barak LS, Terra Pro Product et al. October 2009). "Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands". The Journal of Biological Chemistry. FASEB Journal. 23 (1): 183-193.